Skip to content

Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement

Treatment of Iron Defieciency Anemia

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02957643
Enrollment
50
Registered
2016-11-08
Start date
2016-11-30
Completion date
2017-09-01
Last updated
2020-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of Anemia

Brief summary

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment.

Detailed description

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment

Interventions

DRUGIron

oral treatment

Sponsors

Hippocration General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Age more or equal of 18 years 2. Registration consent 3. Have complete 12h week of pregnancy 4. Hemoglobin levels \<10,5 ptl 5. Hematocrit \< 32 %

Exclusion criteria

1. Age \<18 years 2. Absent registration consent 3. Step of pregnancy less than 12 weeks 4. Coadministration formulations iron oral or parenterally 5. Background of liver kirrosis 6. Background of aimosidirosis 7. Background acquired or chronic aimatochromatosis 8. Aplastic , Hemolytic anemia and chronic diseases 9. Chronic pancreatitis 10. Subjective renal or/and liver disease 11. Hypothyroidism or yperthyreoeidismos

Design outcomes

Primary

MeasureTime frameDescription
Measured and reported effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter with questionnaireup to 24 monthsMeasured and reported effectiveness of iron in the treatment of iron deficiency in pregnant

Secondary

MeasureTime frameDescription
adverse reactionsup to 24 monthsadverse reactions

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026